Clinical trial
Temozolomide in Treating Patients With Leptomeningeal Metastases From a Solid…
NCT00005812 · Dartmouth-Hitchcock Medical Center, Other · Terminated
Key facts
| NCT number | NCT00005812 |
|---|---|
| Title | Temozolomide in Treating Patients With Leptomeningeal Metastases From a Solid Tumor or Lymphoma |
| Official title | A Pilot Phase II Trial of Temozolomide in Leptomeningeal Metastases |
| Lead sponsor | Dartmouth-Hitchcock Medical Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Brain Tumors, Central Nervous System Tumors, Leptomeningeal Metastases |
| Intervention type | Drug |
| Interventions | temozolomide |
| Enrollment | 12 |
| Start date | Jan 1, 2000 |
| Primary completion | May 1, 2004 |
| Completion | May 1, 2004 |
| First posted | Jan 27, 2003 |
| Last update posted | May 14, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: